Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$194 Mln
Revenue (TTM)
$69 Mln
Net Profit (TTM)
$0 Mln
ROE
0.2 %
ROCE
-- %
P/E Ratio
22.6
P/B Ratio
4.3
Industry P/E
54.26
EV/EBITDA
14.4
Div. Yield
0 %
Debt to Equity
0
Book Value
$5.5
EPS
$1
Face value
--
Shares outstanding
8,275,313
CFO
$21.14 Mln
EBITDA
$35.56 Mln
Net Profit
$20.11 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Electromed (ELMD)
| -20.0 | -1.7 | -20.0 | -3.7 | 30.8 | 16.2 | 19.0 |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Electromed (ELMD)
| -1.5 | 168.7 | 4.0 | -19.3 | 32.5 | 13.4 | 69.9 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Electromed (ELMD)
|
23.3 | 194.3 | 68.9 | 9.0 | 16.9 | 20.3 | 22.6 | 4.3 |
| 7.9 | 5,388.2 | 6,552.2 | -530.2 | -4.1 | -9.2 | -- | 0.9 | |
| 278.3 | 7,510.1 | 2,583.2 | 759.9 | 25.2 | 10.8 | 10 | 1.0 | |
| 36.8 | 5,222.6 | 3,436.5 | -8.6 | 2.2 | -0.4 | -- | 2.1 | |
| 112.8 | 6,549.6 | 507.4 | -187.7 | -36.2 | -26.4 | -- | 10.0 | |
| 76.1 | 4,758.4 | 1,541.6 | 233.6 | 21.6 | 21.4 | 21.4 | 4.5 | |
| 178.6 | 9,411.8 | 1,526.9 | -151.5 | 20.0 | -17.1 | -- | 12.9 | |
| 330.4 | 12,964.3 | 1,403.7 | 177.7 | 14.7 | 13.8 | 72.9 | 9.0 | |
| 117.8 | 6,280.4 | 738.3 | 48.9 | 11.4 | 2.4 | 129.6 | 3.0 | |
| 32.1 | 13,716.9 | 6,178.4 | 626.5 | 13.0 | 11.9 | 22.5 | 2.6 |
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The... company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota. Read more
Chief Financial Officer
Mr. Bradley M. Nagel
President, Director & CEO
Mr. James L. Cunniff
Headquarters
New Prague, MN
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Electromed Inc (ELMD) is $23.29 (NYSE) as of 02-Apr-2026 20:00 EDT. Electromed Inc (ELMD) has given a return of 30.83% in the last 3 years.
The P/E ratio of Electromed Inc (ELMD) is 22.61 times as on 02-Apr-2026, a 58 discount to its peers’ median range of 54.26 times.
The P/B ratio of Electromed Inc (ELMD) is 4.31 times as on 02-Apr-2026, a 46 premium to its peers’ median range of 2.95 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
25.44
|
4.44
|
|
2024
|
26.26
|
3.04
|
|
2023
|
29.51
|
2.48
|
|
2022
|
36.53
|
2.46
|
|
2021
|
42.53
|
3.10
|
The 52-week high and low of Electromed Inc (ELMD) are Rs 30.73 and Rs 17.73 as of 04-Apr-2026.
Electromed Inc (ELMD) has a market capitalisation of $ 194 Mln as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Electromed Inc (ELMD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-0.36
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.